OncoMatch/Clinical Trials/NCT05775146
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Is NCT05775146 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for colorectal cancer.
The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Disease stage
Metastatic disease required
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Cannot have received: surgery or ablation for liver lesions
Patients who have undergone previous surgery or ablation for liver lesions
Lab requirements
Liver function
Patients with Child-Pugh C and documented cirrhosis excluded
Patients with Child-Pugh C and documented cirrhosis [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify